BenevolentAI | Investor Conference Presentation Deck | 29 slides · page 26 of 29
The slide is split into two main sections: a case study on baricitinib (left) and a partnership overview with DNDi (right).
Conference presentation · key_takeaways · illustrate_case · overcrowded density
Slide locked Sign in to view
Slide schematic 12/12
image 3/3 list 4/4 paragraph 3/3 title 2/2
Components 12
logo logo logo bullet bullet bullet bullet paragraph paragraph paragraph headline subtitle
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.